National Project Implementation Plan - NVBDCP

(a) To enhance the
effectiveness of
government response
to control malaria and
eliminate kala-azar.
(This will be achieved
by increase in the
number of people
benefiting from
effective prevention,
diagnosis and
treatment services for
malaria control and
kala-azar elimination).
For malaria:
(i) Percentage of fever cases in project
districts receiving a malaria test result no
later than the day after the first contact 11 .
(ii) Percentage of individuals in project
areas belonging to eligible ITN target
population who slept under an ITN during
the previous night.
For kala-azar:
(iii) At least 50% of sampled blocks which
at baseline have not achieved the
elimination goal of less than one kala-azar
case per 10,000 persons, will achieve the
elimination goal by endline.
Review current strategies
and make tactical
changes to the program
plan to improve
effectiveness
Develop clear lessons
about effective strategies
that can be brought to
scale and support the
design of the next phase
of the program
Component One: Improving Access to and Use of Malaria Prevention and
Control Services
1.a. Control of
Malaria
a. i. Percentage of population in
high-risk project areas protected
by LLINs or IRS.
a. ii. Percentage of RDT positive
cases in project districts receiving
ACT no later than the day after
the first contact 12 .
a. iii Percentage of designated
providers of malaria diagnosis and
treatment 13 who have not had an
ACT or RDT stock out during the
last 3 months
a. iv Percentage of villages with a
trained designated provider of
malaria diagnosis and treatment
services.
District-level: to make tactical
changes to the program plan
to improve effectiveness and
correct problems.
State and central level: to
adjust training and
supervision activities; to
identify problems requiring
comprehensive change to the
program plan.
Establish results based
management system to guide
financial investments.
Component Two: Improving Access to and Use of Services for Elimination of
Kala-azar
11 Indicator a.ii is likely to be highly correlated with PDO (i), because in rural areas with limited range of service
providers, individuals who have access to an RDT should also have access to ACT. Population survey data will
also indicate where care was sought. The ideal indicator to assess ACT use would be the % of Pf positive cases in
the population who were given ACT no later that the day after the fever started. But it is not possible to measure
directly because: (a) not all fever cases will seek and receive a test result from designated providers, and (b) not
all fever cases who receive a test result will be Pf positive as most do not have malaria or have only Pv. The ACT
treatment indicator for Pf+ cases can be estimated indirectly, from health service data. The PAD is not proposing
this as a PDO indicator as it cannot be estimated from surveys with adequate precision. It will however be
calculated routinely from service data.
12 “Adults” here would mean individuals 15 years or older. Cases in this age group having a positive test for Pf
will be expected to receive an ACT blister pack, which will be easy to measure in surveys. Younger age-groups
are expected to receive loose artesunate and sulfadoxine-pyrimethamine tablets, which will be difficult to identify
in surveys. Current blood examination rates suggest that a majority of blood tests are currently conducted in the
15+ years age group. Also see footnote #1.
13 These individuals are ASHAs and other providers and Multi-Purpose Health Workers.
96